Literature DB >> 1387654

T cell receptor alpha chain polymorphisms in multiple sclerosis.

L L Hashimoto1, T W Mak, G C Ebers.   

Abstract

Numerous studies have implicated the major histocompatibility complex (MHC) class II alleles, DR2 and DQw1, as multiple sclerosis (MS) susceptibility loci, however, the involvement of other loci is implied by twin studies and the relative lack of haplotype sharing for MHC. To evaluate the role that the TCR alpha chain genes may have in MS susceptibility, three variable (V) alpha polymorphisms were examined for associations in MS patients. Genotype and allele frequencies were compared to four different control groups: unaffected siblings and parents of the MS patients, patients with insulin-dependent diabetes mellitus (IDDM) and healthy unrelated Caucasians. No significant differences in allele and genotype frequencies at these three loci were observed in the MS population compared to the control groups. In addition, we analysed the distribution of haplotype sharing in affected sibling pairs. Among 30 informative families, there was no significant increase in haplotypes shared by affected siblings over that expected based on random segregation. Our results do not support suggestions that germline TCR alpha chain genes contribute to genetic susceptibility in MS.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1387654     DOI: 10.1016/0165-5728(92)90211-3

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  2 in total

1.  Association between susceptibility to Theiler's virus-induced demyelination and T-cell receptor Jbeta1-Cbeta1 polymorphism rather than Vbeta deletion.

Authors:  Y Y Bahk; C A Kappel; G Rasmussen; B S Kim
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

2.  No linkage or association between multiple sclerosis and the myelin basic protein gene in affected sibling pairs.

Authors:  N W Wood; P Holmans; D Clayton; N Robertson; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-10       Impact factor: 10.154

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.